$MRK

AI Analysis

Generated on May 18, 2026

AI Score
70/ 100
Hold$MRK

Merck & Co. Inc.

$MRKNYSEHealthcareLarge-Cap

Merck operates as a healthcare company offering pharmaceutical and vaccine products worldwide.

Market Cap
$280B
Revenue (TTM)
$62.5B
+6.2%
Net Income (TTM)
$14.8B
+8.5%
EPS (TTM)
$5.85
P/E Ratio
18.8
Dividend Yield
2.8%
52-Week Range
$98-$135
Beta
0.45
Dimension Scores
Fundamental
75
Technical
64
Sentiment
68
Risk / Reward
72
Momentum
62
FundTechSentRiskMome
Financial Health
Profitability
80strong
Growth
65moderate
Liquidity
78moderate
Solvency
75moderate
Efficiency
76moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $MRK

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.